Compounds > dipyridamole

dipyridamole and fumarates

dipyridamole has been researched along with fumarates in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, JC; Pharo, RL; Schwartz, A; Sordahl, LA1
Borchert, HH; Gurny, R; Herrmann, W; Kramer, A; Lueckel, B; Ries, A; Siepe, S1
Gurny, R; Kramer, A; Lueckel, B; Ries, A; Siepe, S1
Inoue, R; Kawabata, Y; Onoue, S; Taniguchi, C; Wada, K; Yamada, S; Yamashita, K; Yamauchi, Y1

Other Studies

4 other study(ies) available for dipyridamole and fumarates

ArticleYear
Effects of dipyridamole on mitochondrial electron transport: a new inhibitor at site I.
    Archives of biochemistry and biophysics, 1970, Volume: 138, Issue:1

    Topics: Adenosine Triphosphatases; Animals; Binding Sites; Cattle; Depression, Chemical; Dipyridamole; Electron Transport; Fumarates; Mitochondria, Muscle; Myocardium; NAD; Oxidoreductases; Oxygen; Ubiquinone

1970
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.
    Journal of controlled release : official journal of the Controlled Release Society, 2006, May-01, Volume: 112, Issue:1

    Topics: Chemistry, Pharmaceutical; Citric Acid; Delayed-Action Preparations; Dipyridamole; Electron Spin Resonance Spectroscopy; Fumarates; Hydrogen-Ion Concentration; Hypromellose Derivatives; Methylcellulose; Polymers; Solubility; Succinic Acid; Tablets; Viscosity; Water

2006
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound.
    Drug development and industrial pharmacy, 2008, Volume: 34, Issue:1

    Topics: Chemistry, Pharmaceutical; Dipyridamole; Fumarates; Hydrogen-Ion Concentration; Hypromellose Derivatives; Methylcellulose; Molecular Weight; Solubility; Succinic Acid; Tablets

2008
Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria.
    International journal of pharmaceutics, 2012, Apr-15, Volume: 426, Issue:1-2

    Topics: Achlorhydria; Administration, Oral; Animals; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chromatography, Liquid; Crystallization; Crystallography, X-Ray; Dipyridamole; Disease Models, Animal; Drug Compounding; Drug Stability; Fumarates; Half-Life; Hydrogen-Ion Concentration; Male; Metabolic Clearance Rate; Microscopy, Electron, Scanning; Omeprazole; Phosphodiesterase Inhibitors; Powder Diffraction; Rats; Rats, Sprague-Dawley; Solubility; Spectrometry, Mass, Electrospray Ionization; Technology, Pharmaceutical

2012